Ratings by Roth/MKM (Jason Wittes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/23/2026 | CapsoVision Inc | CV | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | IRadimed Corp | IRMD | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2025 | ARS Pharmaceuticals Inc | SPRY | New Coverage | Buy (N/A) |
10.88 (8.62) |
-20.77% | Details | |
| 7/28/2025 | CapsoVision Inc | CV | New Coverage | Buy (N/A) |
4.27 (6.71) |
57.14% | Details | |
| 7/15/2025 | Zimmer Biomet | ZBH | Upgrade | Buy (Neutral) |
93.86 (91.12) |
-2.92% | Details | |
| 3/18/2025 | Monogram Technologies Inc | MGRM | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2024 | Globus Medical | GMED | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2024 | Monogram Technologies Inc | MGRM | New Coverage | Buy (N/A) |
2.20 (6.00) |
172.73% | Details | |
| 11/11/2024 | TriSalus Life Sciences, Inc. | TLSI | New Coverage | Buy (N/A) |
4.18 (4.29) |
2.63% | Details | |
| 9/25/2024 | Cardiol Therapeutics | CRDL | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | Allurion Technologies | ALUR | New Coverage | Buy (N/A) |
0.62 (0.58) |
-6.45% | Details | |
| 8/13/2024 | Stereotaxis | STXS | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Globus Medical | GMED | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2024 | MindMed | MNMD | New Coverage | Buy (N/A) |
8.84 (15.02) |
69.91% | Details | |
| 6/28/2024 | Journey Medical Corp. | DERM | New Coverage | Buy (N/A) |
5.14 (7.16) |
39.3% | Details | |
| 6/26/2024 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
2.00 (1.21) |
-39.5% | Details | |
| 5/31/2024 | LeMaitre Vascular | LMAT | New Coverage | Buy (N/A) |
78.64 (101.63) |
29.23% | Details | |
| 5/8/2024 | Orthofix International | OFIX | Upgrade | Buy (Neutral) |
13.46 (11.58) |
-13.97% | Details | |
| 5/2/2024 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2024 | Stryker | SYK | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2024 | IRadimed Corp | IRMD | New Coverage | Buy (N/A) |
41.00 (97.03) |
136.66% | Details | |
| 3/7/2024 | Orthofix International | OFIX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2024 | Accuray | ARAY | New Coverage | Buy (N/A) |
2.64 (0.26) |
-90.15% | Details | |
| 1/31/2024 | Stryker | SYK | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2024 | Stereotaxis | STXS | New Coverage | Buy (N/A) |
1.78 (1.55) |
-12.92% | Details | |
| 12/19/2023 | Chemomab Therapeutics | CMMB | New Coverage | Buy (N/A) |
0.51 (1.56) |
205.88% | Details | |
| 10/20/2023 | Globus Medical | GMED | New Coverage | Buy (N/A) |
53.88 (77.00) |
42.91% | Details | |
| 10/20/2023 | Zimmer Biomet | ZBH | New Coverage | Neutral (N/A) |
106.19 (93.86) |
-11.61% | Details | |
| 10/20/2023 | Orthofix International | OFIX | New Coverage | Neutral (N/A) |
12.20 (11.58) |
-5.08% | Details | |
| 10/20/2023 | Stryker | SYK | New Coverage | Buy (N/A) |
270.18 (319.87) |
18.39% | Details | |
| 10/20/2023 | Enovis Corp | ENOV | New Coverage | Buy (N/A) |
48.49 (27.07) |
-44.17% | Details | |
| 10/20/2023 | Alphatec Holdings | ATEC | New Coverage | Buy (N/A) |
11.81 (8.54) |
-27.69% | Details |
